ADEQUAN POLYSULFATED GLYCOSAMINOGLYCAN INJECTION: 100MG PER ML
Land: Australien
Sprog: engelsk
Kilde: APVMA (Australian Pesticides and Veterinary Medicines Authority)
Indlægsseddel
(PIL)
24-01-1996
Produktets egenskaber
(SPC)
01-07-2013
Aktiv bestanddel:
GLYCOSAMINOGLYCAN POLYSULFATE
Tilgængelig fra:
ELANCO AUSTRALASIA PTY LTD
INN (International Name):
polysulfated glycosaminoglyca(100mg/mL)
Lægemiddelform:
PARENTERAL LIQUID/SOLUTION/SUSPENSION
Sammensætning:
GLYCOSAMINOGLYCAN POLYSULFATE EMULSIFIERS & SURFACTANTS Active 100.0 mg/ml
Enheder i pakken:
7 x 5mL; Unit = 5mL
Klasse:
VM - Veterinary Medicine
Fremstillet af:
ELANCO AUSTRALASIA
Terapeutisk gruppe:
HORSE | COLT | DONKEY | ENDURANCE HORSE | FILLY | FOAL | GELDING | HIGH PERFORMANCE HORSES | HORSES AT STUD | MARE | PACER | POL
Terapeutisk område:
MUSCULOSKELETAL SYSTEM
Terapeutiske indikationer:
DEGENERATIVE ASEPTIC JOINT DISEASE | TRAUMATIC DEGENERATIVE JOINT D
Produkt oversigt:
Poison schedule: 4; Withholding period: WHP: MEAT - 28 DAYS; Host/pest details: HORSE: [DEGENERATIVE ASEPTIC JOINT DISEASE]; Poison schedule: 4; Withholding period: ; Host/pest details: HORSE: [DEGENERATIVE ASEPTIC JOINT DISEASE]; An aid in the treatment of traumatic or degenerative aseptic joint disease for horses.
Autorisation status:
Registered
Autorisation dato:
2023-07-01
Indlægsseddel
APPROVED
LABEL
Info
PEST
Verified
APPROVED
LABEL
APPROVED
LABEL
Læs hele dokumentet
Produktets egenskaber
PRODUCT NAME: ADEQUAN® POLYSULFATED GLYCOSAMINOGLYCAN
INJECTION: 100MG PER ML
PAGE NO:
1 OF 4
DATE OF ISSUE:
AUGUST 2011
MATERIAL SAFETY DATA SHEET
Novartis Animal Health Australasia Pty Ltd
SECTION 1 _-_ IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY
COMPANY DETAILS:
NOVARTIS ANIMAL HEALTH AUSTRALASIA PTY LIMITED
PHONE: (02) 9805 3555
ACN 076 745 198
FAX: (02) 9888 8387
54 WATERLOO ROAD,
NORTH RYDE NSW 2113
Identification of the substance or mixture
SUBSTANCE NO.
000070003151
NAH SUBSTANCE CODE:
A-20117 A
TRADE NAME:
ADEQUAN I.M. INJ
PRODUCT NAME:
ADEQUAN Polysulfated Glycosaminoglycan Injection: 100mg per
mL
REVISION DATE:
August 2011
SECTION 2 HAZARDS IDENTIFICATION
RISK ADVICE TO MAN AND THE ENVIRONMENT
POTENTIAL HEALTH EFFECTS:
No hazards to be specially mentioned.
POTENTIAL ENVIRONMENTAL
EFFECTS:
No hazards to be specially mentioned.
SECTION 3 COMPOSITION / INFORMATION ON INGREDIENTS
CHEMICAL NATURE
USE:
Veterinary medicinal product.
TYPE OF PREPARATION:
Solution for injection.
ACTIVE INGREDIENTS:
AHC 2218566 A Polysulphated glycosaminoglycan.
SECTION 4 FIRST AID MEASURES
GENERAL ADVICE:
If you feel unwell, seek medical advice (show the label where
possible).
INHALATION:
Remove to fresh air.
SKIN CONTACT:
Wash off immediately with plenty of water. Take
off contaminated
clothing and shoes immediately.
EYE CONTACT:
Læs hele dokumentet
